iPSC-derived mesenchymal stem cells exert SCF-dependent recovery of cigarette smoke-induced apoptosis/proliferation imbalance in airway cells

Journal of Cellular and Molecular Medicine

Volumn 21, Issue 2, 2017, Pages 265-277

  Li, Xiang ^a   Zhang, Yuelin ^a   Liang, Yingmin ^a   Cui, Yuting ^a   Yeung, Sze C ^a   Ip, Mary S M ^a   Tse, Hung Fat ^a   Lian, Qizhou ^a,b   Mak, Judith C W ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (China)

Author keywords

apoptosis; cigarette smoke; mesenchymal stem cell; proliferation; stem cell factor

Indexed keywords

8 ISOPROSTANE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CIGARETTE SMOKE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; STEM CELL FACTOR; CONDITIONED MEDIUM; STEM CELL FACTOR RECEPTOR;

AIRWAY CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL THERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MESENCHYMAL STEM CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; TUNEL ASSAY; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; CELL LINE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; EPITHELIUM; INDUCED PLURIPOTENT STEM CELL; LUNG; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; NEUTROPHIL CHEMOTAXIS; OXIDATIVE STRESS; PATHOLOGY; PHARMACOLOGY; SMOKING;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; EPITHELIUM; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFLAMMATION; LUNG; MACROPHAGES; MESENCHYMAL STROMAL CELLS; NEUTROPHIL INFILTRATION; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-KIT; RATS; SMOKING; STEM CELL FACTOR;

EID: 84988312199     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12962     Document Type: Article

References (53)

1. Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med. 2007; 4: e112.
2. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370: 741–50.
3. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000; 343: 269–80.
4. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3: e442.
5. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012; 379: 1341–51.
6. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest. 2009; 135: 173–80.
7. Demedts IK, Demoor T, Bracke KR, et al. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res. 2006; 7: 53.
8. Teo AK, Vallier L. Emerging use of stem cells in regenerative medicine. Biochem J. 2010; 428: 11–23.
9. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861–72.
10. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318: 1917–20.
11. Lian Q, Zhang Y, Zhang J, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 2010; 121: 1113–23.
12. Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004; 109: 1615–22.
13. Zhang Y, Liao S, Yang M, et al. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Cell Transplant. 2012; 21: 2225–39.
14. Wei H, Tan G, Manasi, et al. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res. 2012; 9: 87–100.
15. Giuliani M, Oudrhiri N, Noman ZM, et al. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood. 2011; 118: 3254–62.
16. Buchman AS, Boyle PA, Wilson RS, et al. Pulmonary function, muscle strength and mortality in old age. Mech Ageing Dev. 2008; 129: 625–31.
17. Karrasch S, Holz O, Jorres RA. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med. 2008; 102: 1215–30.
18. Kojima S, Sakakibara H, Motani S, et al. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. J Epidemiol. 2007; 17: 54–60.
19. Sun YQ, Deng MX, He J, et al. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells. 2012; 30: 2692–9.
20. Li X, Zhang Y, Yeung SC, et al. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage. Am J Respir Cell Mol Biol. 2014; 51: 455–65.
21. Weiss DJ, Bertoncello I, Borok Z, et al. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc. 2011; 8: 223–72.
22. Lennartsson J, Ronnstrand L. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev. 2012; 92: 1619–49.
23. Chan KH, Ho SP, Yeung SC, et al. Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir Med. 2009; 103: 1746–54.
24. Lau WK, Chan SC, Law AC, et al. The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced IL-8 production in human bronchial epithelial cells. Toxicol Sci. 2012; 125: 569–77.
25. Kwon YW, Heo SC, Jeong GO, et al. Tumor necrosis factor-alpha-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. Biochim Biophys Acta. 2013; 1832: 2136–44.
26. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 1993; 81: 1607–13.
27. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; 182: 311–22.
28. Nur EKA, Gross SR, Pan Z, et al. Nuclear translocation of cytochrome c during apoptosis. J Biol Chem. 2004; 279: 24911–4.
29. Rico de Souza A, Zago M, Pollock SJ, et al. Genetic ablation of the aryl hydrocarbon receptor causes cigarette smoke-induced mitochondrial dysfunction and apoptosis. J Biol Chem. 2011; 286: 43214–28.
30. Scovassi AI, Soldani C, Veneroni P, et al. Changes of mitochondria and relocation of the apoptosis-inducing factor during apoptosis. Ann N Y Acad Sci. 2009; 1171: 12–7.
31. Wang CH, Verma S, Hsieh IC, et al. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol. 2007; 27: 540–7.
32. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187: 347–65.
33. Weiss DJ. Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. Ann Am Thorac Soc. 2013; 10: S45–97.
34. Guan XJ, Song L, Han FF, et al. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem. 2013; 114: 323–35.
35. Huh JW, Kim SY, Lee JH, et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol. 2011; 301: L255–66.
36. Li Y, Gu C, Xu W, et al. Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema. Respir Res. 2014; 15: 120.
37. Schweitzer KS, Johnstone BH, Garrison J, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med. 2011; 183: 215–25.
38. Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013; 143: 1590–8.
39. Phinney DG. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem. 2012; 113: 2806–12.
40. Tzouvelekis A, Paspaliaris V, Koliakos G, et al. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med. 2013; 11: 171.
41. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012; 10: 709–16.
42. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012; 12: 383–96.
43. Francois M, Galipeau J. New insights on translational development of mesenchymal stromal cells for suppressor therapy. J Cell Physiol. 2012; 227: 3535–8.
44. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004; 364: 709–21.
45. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350: 2645–53.
46. Detmers PA, Powell DE, Walz A, et al. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol. 1991; 147: 4211–7.
47. Zhang X, Zheng H, Zhang H, et al. Increased interleukin (IL)-8 and decreased IL-17 production in chronic obstructive pulmonary disease (COPD) provoked by cigarette smoke. Cytokine. 2011; 56: 717–25.
48. Ramos CD, Heluy-Neto NE, Ribeiro RA, et al. Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1. Cytokine. 2003; 21: 214–23.
49. al-Mokdad M, Shibata F, Nakagawa H. Effects of cytokine-induced neutrophil chemoattractants (CINCs) on shape change, adhesiveness and phagocytosis of rat neutrophils. Biol Pharm Bull. 1997; 20: 920–3.
50. Montuschi P, Barnes PJ, Roberts LJ 2nd. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004; 18: 1791–800.
51. Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 2000; 162 (3 Pt 1): 1175–7.
52. Pratico D, Basili S, Vieri M, et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med. 1998; 158: 1709–14.
53. Lindsey JY, Ganguly K, Brass DM, et al. c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice. Am J Respir Crit Care Med. 2011; 183: 1644–52.